Centene Aktie
59,65USD | -0,41USD | -0,68% |
WKN: 766458 / ISIN: US15135B1017
Aktionärsstruktur
Inhaber | in % |
---|---|
Freefloat | 98,91 |
The Vanguard Group, Inc. | 12,12 |
Vanguard Group, Inc. (Subfiler) | 11,43 |
Harris Associates LP | 5,21 |
Harris Associates LP | 5,21 |
State Street Corp. | 4,65 |
Capital Research & Management Co. (World Investors) | 4,47 |
Capital Research & Management Co. (World Investors) | 4,47 |
Norges Bank (13F) | 4,20 |
Vanguard Total Stock Market ETF | 3,29 |
Wellington Management Co. LLP (Wellington Breakout) | 3,17 |
BlackRock Fund Advisors | 3,06 |
Vanguard 500 Index Fund | 2,76 |
Geode Capital Management LLC | 2,51 |
Politan Capital Management LP | 2,40 |
*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.
Personal
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Personal am Ende des Jahres | 56 600 | 71 300 | 72 500 | 74 300 | 76 000 |
Umsatz pro Mitarbeiter in Mio. EUR | 1,32 | 1,56 | 1,74 | 1,95 | 2,03 |
Bilanz (in Mio. USD) - Aktiva
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Summe Umlaufvermögen | 20 323 | 23 393 | 28 497 | 30 128 | 40 756 |
Summe Anlagevermögen | 20 671 | 46 450 | 51 263 | 48 410 | 45 142 |
Summe Aktiva | 40 994 | 69 843 | 79 760 | 78 538 | 85 898 |
Bilanz (in Mio. USD) - Passiva
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Gesamtverschuldung/ -verbindlichkeiten | 14 509 | 18 317 | 22 661 | 21 333 | 18 877 |
Summe Fremdkapital | 28 302 | 43 881 | 52 738 | 54 301 | 59 942 |
Summe Eigenkapital | 12 692 | 25 962 | 27 022 | 24 237 | 25 956 |
Summe Passiva | 40 994 | 69 843 | 79 760 | 78 538 | 85 898 |
Adresse
7700 Forsyth Boulevard, 63105 St. Louis | |
Telefon | +1 (314) 725-4477 |
Internet | http://www.centene.com |
Management
Alice Hm Chen
Chief Health Officer |
Andrew Lynn Asher
Chief Financial Officer & Executive Vice President |
Anika Gardenhire
Chief Customer Experience Officer |
Ashlee Knuckey
Chief Risk, Ethics & Compliance Officer |
Beau Garverick
Senior Vice President |
Brian P. LeClaire
Chief Information Officer |
Chan See Wing Arvan
Chief Operating Officer-International & Senior VP |
Christopher A. Koster
Secretary, Executive VP & General Counsel |
Christopher J. Coughlin
Independent Director |
Colin Toney
Executive Vice President-Mergers & Acquisitions |
David P. Thomas
Executive Vice President-Markets |
Frederick H. Eppinger
Chairman |
Gerald Roberts
Vice President-Strategy & Business Development |
H. James Dallas
Independent Director |
Jennifer Gilligan
Senior VP-Finance & Investor Relations |
Jessica L. Blume
Independent Director |
Jonathan L. Dinesman
Executive Vice President-External Affairs |
Katie N. Casso
Chief Accounting Officer, Senior VP & Controller |
Kenneth A. Burdick
Director |
Kenneth J. Fasola
President |
Kevin J. Counihan
Senior Vice President-Products |
Lori J. Robinson
Independent Director |
Michael A. Carson
President-Medicare & CEO-Medicare |
Monte E. Ford
Independent Director |
Nathan Landsbaum
CEO-Markets & Medicaid |
Richard Fisher
Senior Vice President |
Sarah McGinty London
Chief Executive Officer & Director |
Susan Smith
Chief Operating Officer |
Suzy DePrizio
Chief Marketing Officer & Senior Vice President |
Tanya McNally
Chief People Officer & Senior Vice President |
Theodore Rapp Samuels
Independent Director |
Thomas R. Greco
Director |
Wade A. Rakes
Chief Growth Officer |
Wayne S. DeVeydt
Independent Director |